Acute Kidney Injury
Conditions
Keywords
Acute Kidney Injury, Intra-Abdominal Pressure, Renal Perfusion Pressure, Cardiac Surgery
Brief summary
The goal of this clinical trial is to determine whether monitoring intra-abdominal pressure (IAP) and adjusting blood pressure accordingly to maintain optimal renal perfusion pressure can reduce the risk of acute kidney injury (AKI) after cardiac surgery. The main question this study aims to answer is: \- Does IAP-guided blood pressure management improve renal perfusion and lower AKI rates in cardiac surgery patients? Participants will be randomly assigned to one of two groups: * Control Group: Standard ICU care with a conventional Foley catheter. * Intervention Group: Standard ICU care with an IAP-monitoring Foley catheter, where blood pressure is adjusted based on IAP readings to optimize renal perfusion pressure. All participants will undergo routine blood and urine tests to assess kidney function during their hospital stay. This study will help determine whether IAP-based hemodynamic management can improve postoperative kidney outcomes and provide a new strategy for AKI prevention in cardiac surgery patients.
Interventions
The Conventional Foley Catheter is a standard urinary catheter used in ICU care to monitor urine output. It does not have intra-abdominal pressure (IAP) monitoring capabilities.
The Accuryn Foley Catheter is an FDA-approved urinary catheter with continuous intra-abdominal pressure (IAP) monitoring capability.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults Undergoing cardiac surgery with cardiopulmonary bypass * Left ventricular ejection fraction (LVEF) \< 50%
Exclusion criteria
* Current pregnancy * ESRD or AKI on dialysis * Currently on ECMO or Impella * Emergent surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of Postoperative Acute Kidney Injury (AKI) as defined by KDIGO Criteria | Perioperative. | Acute Kidney Injury will be defined using the KDIGO criteria: an increase in serum creatinine by ≥0.3 mg/dL within 48 hours or an increase to ≥1.5 times the baseline. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| ICU Length of Stay | Perioperative | The number of days from the day of surgery until discharge from the ICU |
| Hospital Length of Stay | Perioperative | The number of days from the day of surgery until discharge from the hospital (including both ICU and general ward) |
Countries
United States